Rochdi Chaymae, Ouadrhiri Meriem, Bellajdel Ibtissam, Taheri Hafsa, Saadi Hanane, Mimouni Ahmed, Choukri Mohammed
Maternal-Child and Mental Health Research Laboratory, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
Medically Assisted Procreation Unit, Central Laboratory, Mohammed VI University Hospital Center, Oujda, Morocco.
Clin Exp Reprod Med. 2025 Sep;52(3):259-267. doi: 10.5653/cerm.2024.07703. Epub 2025 Jul 10.
This study emphasizes the role of oxidative stress in the pathogenesis of male infertility-including varicocele-and supports the utility of antioxidant supplementation. The aim of our study is to evaluate the effectiveness of multiantioxidant therapy in improving semen quality, reducing the DNA fragmentation index, and increasing pregnancy rates in oligoasthenozoospermic (OA) patients with different grades of varicocele.
We conducted a prospective study of infertile men with OA and varying grades of varicocele. Serum and semen samples were collected at baseline and after 6 months of treatment from subjects with varicocele grades 0, 1, 2, and 3. Sperm DNA damage, reproductive hormones, and pregnancy rates were evaluated.
Significant differences in mean sperm count, total sperm count, sperm motility, and normal sperm morphology were observed among groups G1, G2, G3, and G4 (p<0.0001). Sperm DNA integrity improved significantly in patients with varicocele after oral antioxidant therapy. Pregnancy achieved by intrauterine insemination was observed in 11%, 9%, 1%, and 0.7% of couples in groups G1, G2, G3, and G4, respectively. Additionally, spontaneous pregnancy occurred in 6% and 3% of couples with varicocele grade 0 and grade 1, respectively, after multiantioxidant supplementation. No significant pregnancy rate was observed in groups G3 and G4.
Multiantioxidant therapy produced marked therapeutic benefits in patients with grade 0 and grade 1 varicocele and served as a useful adjuvant in managing varicocele-related infertility.
本研究强调氧化应激在男性不育症(包括精索静脉曲张)发病机制中的作用,并支持补充抗氧化剂的实用性。我们研究的目的是评估多抗氧化剂疗法对改善少弱精子症(OA)合并不同等级精索静脉曲张患者精液质量、降低DNA碎片化指数及提高妊娠率的有效性。
我们对患有OA及不同等级精索静脉曲张的不育男性进行了一项前瞻性研究。从精索静脉曲张0级、1级、2级和3级的受试者中,在基线时和治疗6个月后采集血清和精液样本。评估精子DNA损伤、生殖激素和妊娠率。
在G1、G2、G3和G4组之间,平均精子计数、总精子计数、精子活力和正常精子形态存在显著差异(p<0.0001)。口服抗氧化剂治疗后,精索静脉曲张患者的精子DNA完整性显著改善。G1、G2、G3和G4组中,分别有11%、9%、1%和0.7%的夫妇通过宫内授精实现妊娠。此外,补充多抗氧化剂后,精索静脉曲张0级和1级的夫妇中分别有6%和3%自然受孕。G3组和G4组未观察到显著的妊娠率。
多抗氧化剂疗法对0级和1级精索静脉曲张患者产生了显著的治疗效果,是治疗精索静脉曲张相关不育症的有效辅助方法。